Cargando...

Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation

Lung cancer represents the leading cause of cancer-related deaths in men and women worldwide. Targeted therapeutics, including the epidermal growth factor receptor (EGFR) inhibitor erlotinib, have recently emerged as clinical alternatives for the treatment of non-small cell lung cancer (NSCLC). Howe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Cycle
Main Authors: Stahlhut, Carlos, Slack, Frank J
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4615025/
https://ncbi.nlm.nih.gov/pubmed/25714397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2014.1003008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!